21st Century Cures Conversation Continues Around the Country

August 15, 2014

After six hearings and three roundtables in Washington over the past several months, Energy and Commerce Committee members are taking the 21st Century Cures conversation back home and around the country. Committee member Rep. Gus Bilirakis (R-FL) is hosting two roundtable events, the first of which will be held Tuesday at 1:30 PM in Lutz, Florida. Additionally, Vice Chairman of the Health and Oversight and Investigations Subcommittees Michael C. Burgess, M.D. (R-TX) will participate in an event hosted by the Manhattan Institute and the Tufts Center for the Study of Drug Development in Boston on Monday, August 25.

Learn more about 21st Century Cures online here, follow the initiative on Twitter and Facebook, and join the conversation using #Path2Cures

August 14, 2014

Bilirakis Hosts Two Health Care Roundtables

LUTZ — U.S. Rep. Gus Bilirakis has planned two "21st Century Cures" roundtables to discuss how to get better treatments to patients more quickly.

The first event, called "Patients and the Patient Perspective," is at 1:30 p.m. Tuesday at the Bethany Center, 18150 Bethany Center Dr., Lutz. The roundtable will feature representatives from the Leukemia and Lymphoma Society, the Alpha-1 Foundation, the Parent Project for Muscular Dystrophy, the ALS Association's Florida chapter and two dysautonomia patient advocates.

The second event, called "Spurring Innovation, Advancing Treatments, and Incentivizing Investment" is at 1:30 p.m. Aug. 22, also at the Bethany Center. It will feature representatives from the Department of Neurology at the Morsani College of Medicine at USF, the USF Neuroscience Collaborative, USF's Byrd Alzheimer's Institute, Nemour's Children's Hospital, NDH Medical, Inc., the Florida Medical Manufacturers Consortium, Moffitt Cancer Center and Rochester Electro-Medical, Inc. …

Read the article online HERE

Building A 21st Century Health Care System: Aligning Policy, Accelerating Cures, Delivering Hope

America is on the cusp of a Golden Age in medicine. Significant advances in our understanding of human physiology and genetics are merging with cutting-edge technologies and bioengineering, enabling us to attack the root causes of complex diseases.

To fully realize these life-saving and life-improving opportunities, we need to find new ways to accelerate the development, lower the cost, and reduce the risk of bringing new medicines to market. Moreover, without reforms, the U.S. could easily find itself ceding its current global leadership position in bio-innovation.

The Tufts Center for the Study of Drug Development, in partnership with the Manhattan Institute and its Project FDA, is bringing together key policymakers, patient advocates, leading academics, and industry experts to assess roadblocks to bio-innovation and explore how to create a better paradigm for the discovery and development of new medicines and delivery to patients. With Congress poised to take action on this challenge—witness the launch of its bipartisan 21st Century Cures Initiative—this Boston symposium will be the first in a series of public conversations about the reforms needed to advance innovation and create an effective and affordable health care system for the 21st Century. …

 

More information online HERE.

###